Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer cultures

Journal of Cellular Biochemistry

Volumn 111, Issue 6, 2010, Pages 1642-1651

  Claus, S ^a,b,f   Aubert Foucher, E ^a,f   Demoor, M ^c   Camuzeaux, B ^d   Paumier, A ^a,f   Piperno, M ^e   Damour, O ^a,b,f   Duterque Coquillaud, M ^d   Galera P ^c   Mallein Gerin, F ^a,f  

^a UNIVERSITÉ DE LYON   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

^d UNIV LILLE   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f UNIVERSITÉ LYON 1   (France)

Author keywords

autologous chondrocyte transplantation; bone morphogenetic protein 2; type II collagen

Indexed keywords

AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 2; OSTEOCALCIN; TRANSCRIPTION FACTOR SOX9;

ARTICLE; CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL EXPANSION; CELL ISOLATION; CHONDROGENESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 78649782968     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22897     Document Type: Article

References (43)

1. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA,. 2003. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine (Phila, PA 1976) 28: 1219-1224; discussion 1225.
2. Blunk T, Sieminski AL, Appel B, Croft C, Courter DL, Chieh JJ, Goepferich A, Khurana JS, Gooch KJ,. 2003. Bone morphogenetic protein 9: A potent modulator of cartilage development in vitro. Growth Factors 21: 71-77.
3. Bobacz K, Gruber R, Soleiman A, Erlacher L, Smolen JS, Graninger WB,. 2003. Expression of bone morphogenetic protein 6 in healthy and osteoarthritic human articular chondrocytes and stimulation of matrix synthesis in vitro. Arthritis Rheum 48: 2501-2508.
4. Boden SD, Kang J, Sandhu H, Heller JG,. 2002. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine (Phila, PA 1976) 27: 2662-2673.
5. Bonaventure J, Kadhom N, Cohen-Solal L, Ng KH, Bourguignon J, Lasselin C, Freisinger P,. 1994. Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res 212: 97-104.
6. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L,. 1994. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331: 889-895.
7. Burkus JK, Dorchak JD, Sanders DL,. 2003. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine (Phila, PA 1976) 28: 372-377.
8. Cortial D, Gouttenoire J, Rousseau CF, Ronziere MC, Piccardi N, Msika P, Herbage D, Mallein-Gerin F, Freyria AM,. 2006. Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds with therapeutic potential in osteoarthritis. Osteoarthritis Cartilage 14: 631-640.
9. Dell'Accio F, De Bari C, El Tawil NM, Barone F, Mitsiadis TA, O'Dowd J, Pitzalis C,. 2006. Activation of WNT and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther 8: R139.
10. Fernandez-Lloris R, Vinals F, Lopez-Rovira T, Harley V, Bartrons R, Rosa JL, Ventura F,. 2003. Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells. Mol Endocrinol 17: 1332-1343.
11. Flechtenmacher J, Huch K, Thonar EJ, Mollenhauer JA, Davies SR, Schmid TM, Puhl W, Sampath TK, Aydelotte MB, Kuettner KE,. 1996. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 39: 1896-1904.
12. Freyria AM, Ronziere MC, Cortial D, Galois L, Hartmann D, Herbage D, Mallein-Gerin F,. 2009. Comparative phenotypic analysis of articular chondrocytes cultured within type I or type II collagen scaffolds. Tissue Eng Part A 15: 1233-1245.
13. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S,. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A (Suppl 1): S151-S158.
14. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ,. 2003. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 85-A (Suppl 3): 59-66.
15. Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S, Suzuki R, Sandell LJ, Ochi T,. 2006. Pro-inflammatory cytokine tumor necrosis factor-alpha induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 281: 27229-27241.
16. Geesink RG, Hoefnagels NH, Bulstra SK,. 1999. Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J Bone Joint Surg Br 81: 710-718.
17. Gooch KJ, Blunk T, Courter DL, Sieminski AL, Vunjak-Novakovic G, Freed LE,. 2002. Bone morphogenetic proteins-2, -12, and -13 modulate in vitro development of engineered cartilage. Tissue Eng 8: 591-601.
18. Granjeiro JM, Oliveira RC, Bustos-Valenzuela JC, Sogayar MC, Taga R,. 2005. Bone morphogenetic proteins: From structure to clinical use. Braz J Med Biol Res 38: 1463-1473.
19. Groeneveld EH, Burger EH,. 2000. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 142: 9-21.
20. Grunder T, Gaissmaier C, Fritz J, Stoop R, Hortschansky P, Mollenhauer J, Aicher WK,. 2004. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage 12: 559-567.
21. Hauschka PV, Lian JB, Cole DE, Gundberg CM,. 1989. Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol Rev 69: 990-1047.
22. Hautier A, Salentey V, Aubert-Foucher E, Bougault C, Beauchef G, Ronziere MC, de Sobarnitsky S, Paumier A, Galera P, Piperno M, Damour O, Mallein-Gerin F,. 2008. Bone morphogenetic protein-2 stimulates chondrogenic expression in human nasal chondrocytes expanded in vitro. Growth Factors 20: 201-211.
23. Krawczak DA, Westendorf JJ, Carlson CS, Lewis JL,. 2009. Influence of bone morphogenetic protein-2 on the extracellular matrix, material properties, and gene expression of long-term articular chondrocyte cultures: Loss of chondrocyte stability. Tissue Eng Part A 15: 1247-1255.
24. Kumar D, Lassar AB,. 2009. The transcriptional activity of Sox9 in chondrocytes is regulated by RhoA signaling and actin polymerization. Mol Cell Biol 29: 4262-4273.
25. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B,. 1997. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17: 2336-2346.
26. Lin L, Zhou C, Wei X, Hou Y, Zhao L, Fu X, Zhang J, Yu C,. 2008. Articular cartilage repair using dedifferentiated articular chondrocytes and bone morphogenetic protein 4 in a rabbit model of articular cartilage defects. Arthritis Rheum 58: 1067-1075.
27. Mallein-Gerin F, Olsen BR,. 1993. Expression of simian virus 40 large T (tumor) oncogene in mouse chondrocytes induces cell proliferation without loss of the differentiated phenotype. Proc Natl Acad Sci USA 90: 3289-3293.
28. Marlovits S, Hombauer M, Truppe M, Vecsei V, Schlegel W,. 2004. Changes in the ratio of type-I and type-II collagen expression during monolayer culture of human chondrocytes. J Bone Joint Surg Br 86: 286-295.
29. Martin I, Jakob M, Schafer D, Dick W, Spagnoli G, Heberer M,. 2001. Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9: 112-118.
30. McAlinden A, Johnstone B, Kollar J, Kazmi N, Hering TM,. 2008. Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation. Matrix Biol 27: 254-266.
31. Murphy CL, Polak JM,. 2004. Control of human articular chondrocyte differentiation by reduced oxygen tension. J Cell Physiol 199: 451-459.
32. Murphy CL, Sambanis A,. 2001. Effect of oxygen tension and alginate encapsulation on restoration of the differentiated phenotype of passaged chondrocytes. Tissue Eng 7: 791-803.
33. Park Y, Sugimoto M, Watrin A, Chiquet M, Hunziker EB,. 2005. BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium-derived progenitor cells cultured in three-dimensional alginate hydrogel. Osteoarthritis Cartilage 13: 527-536.
34. Piperno M, Moyen B, Carrillon Y, Vignon E, Damour O,. 2005. Greffe de chondrocytes autologues dans les lésions du cartilage fémoral: l'expérience lyonnaise. Revue du rhumatisme 72: 909-910.
35. Ronziere MC, Aubert-Foucher E, Gouttenoire J, Bernaud J, Herbage D, Mallein-Gerin F,. 2005. Integrin alpha1beta1 mediates collagen induction of MMP-13 expression in MC615 chondrocytes. Biochim Biophys Acta 1746: 55-64.
36. Rountree RB, Schoor M, Chen H, Marks ME, Harley V, Mishina Y, Kingsley DM,. 2004. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol 2: e355.
37. Ryan MC, Sandell LJ,. 1990. Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA. J Biol Chem 265: 10334-10339.
38. Sailor LZ, Hewick RM, Morris EA,. 1996. Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture. J Orthop Res 14: 937-945.
39. Schmid TM, Linsenmayer TF,. 1985. Developmental acquisition of type X collagen in the embryonic chick tibiotarsus. Dev Biol 107: 373-381.
40. Stewart MC, Saunders KM, Burton-Wurster N, Macleod JN,. 2000. Phenotypic stability of articular chondrocytes in vitro: The effects of culture models, bone morphogenetic protein 2, and serum supplementation. J Bone Miner Res 15: 166-174.
41. Valcourt U, Ronziere MC, Winkler P, Rosen V, Herbage D, Mallein-Gerin F,. 1999. Different effects of bone morphogenetic proteins 2, 4 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line. Exp Cell Res 251: 264-274.
42. Valcourt U, Gouttenoire J, Moustakas A, Herbage D, Mallein-Gerin F,. 2002. Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem 277: 33545-33558.
43. Valcourt U, Gouttenoire J, Aubert-Foucher E, Herbage D, Mallein-Gerin F,. 2003. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett 545: 115-119.